Status:
COMPLETED
Assessment of Ambulatory Polygraphy in the Detection of Sleep Apnea in Multiple System Atrophy (SAMSA)
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Sleep Apnea Syndromes
Multiple System Atrophy
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether ambulatory polygraphy during a short hospitalization in a neurology unit has the same performance than inpatient polysomnography, the actual gold stan...
Detailed Description
MSA patients frequently show sleep apnea. Inpatient polysomnography is currently the gold standard in the diagnosis of sleep apnea. However, its limited availability and high costs restrain a systemat...
Eligibility Criteria
Inclusion
- Diagnosis of "probable" MSA according to current consensus criteria (Gilman et al. 1999, PMID 10223419)
- Age 30-80 years
- Oral informed consent of patient or representative
- Patient requiring hospitalization in a neurology unit
Exclusion
- Progressive cancer
- Significant cognitive impairment (MMSE\<24)
- Sleep apnea
- Respiratory disorder
- Less than one year since previous polysomnography or ambulatory polygraphy
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00743561
Start Date
June 1 2008
End Date
January 1 2011
Last Update
April 30 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Bordeaux - Hôpital Pellegrin
Bordeaux, France, 33096
2
CHU de Bordeaux - Hôpital du Haut-Lévêque - Département de Neurologie - Centre de référence nationale maladie rare AMS
Pessac, France, 33604